Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Aug 12:1:108-11.
doi: 10.7150/jca.1.108.

Adrenocortical carcinoma and synchronous malignancies

Affiliations
Case Reports

Adrenocortical carcinoma and synchronous malignancies

Marlon A Guerrero et al. J Cancer. .

Abstract

Objective: Adrenocortical carcinoma (ACC) is an aggressive tumor that accounts for 0.02% of all reported cancers. ACC commonly arises in a sporadic manner, but may also manifest as part of a familial syndrome. Regardless of the setting, ACC rarely arises concurrent with other malignant tumors.

Methods: In this report we describe a 32-year-old woman who on work-up for abnormal vaginal bleeding was diagnosed with synchronous uterine adenocarcinoma, ovarian adenocarcinoma and ACC. We also provide a literature review of the past 20 years to identify other patients with ACC and synchronous malignant tumors, and those with familial syndromes associated with an increased risk of developing ACC.

Results and conclusions: To our knowledge this is the first report of a patient with synchronous malignant tumors of the uterus, ovary and adrenal gland. Review of the literature revealed only 5 other cases in which a patient had concurrent ACC and malignant tumors in other organs.

Keywords: Adrenocortical carcinoma; Ovarian cancer; Synchronous malignancies; Uterine cancer; and Hereditary syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1
Computed tomography scan showing a) 14.5 x 10.7 cm left adrenal mass with areas of necrosis and internal calcifications, and b) 16.8 x 14.8 cm pelvic mass. Arrows denote the tumors.
Figure 2
Figure 2
Magnetic resonance imaging scan showing a) 2.3 cm uterine mass and b) 15.5 x 15.3 cm left adnexal mass. Arrows denote the tumors.

References

    1. Schteingart DE, Doherty GM, Gauger PG. et al.Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12:667–680. - PubMed
    1. Kuruba R, Gallagher SF. Current management of adrenal tumors. Curr Opin Oncol. 2008;20:34–46. - PubMed
    1. Soon PS, McDonald KL, Robinson BG, Sidhu SB. Molecular markers and the pathogenesis of adrenocortical cancer. Oncologist. 2008;13:548–561. - PubMed
    1. McNicol AM. A diagnostic approach to adrenal cortical lesions. Endocr Pathol. 2008;19:241–251. - PubMed
    1. Kebebew E, Reiff E, Duh QY, Clark OH, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg. 2006;30:872–878. - PubMed

Publication types